Sameer S. Kadri

8.2k total citations · 4 hit papers
101 papers, 4.8k citations indexed

About

Sameer S. Kadri is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Infectious Diseases. According to data from OpenAlex, Sameer S. Kadri has authored 101 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Epidemiology, 29 papers in Applied Microbiology and Biotechnology and 26 papers in Infectious Diseases. Recurrent topics in Sameer S. Kadri's work include Sepsis Diagnosis and Treatment (34 papers), Antibiotic Use and Resistance (29 papers) and Nosocomial Infections in ICU (19 papers). Sameer S. Kadri is often cited by papers focused on Sepsis Diagnosis and Treatment (34 papers), Antibiotic Use and Resistance (29 papers) and Nosocomial Infections in ICU (19 papers). Sameer S. Kadri collaborates with scholars based in United States, Canada and Jordan. Sameer S. Kadri's co-authors include Michael Klompas, Chanu Rhee, Robert L. Danner, Jeffrey R. Strich, Yi Ling Lai, John P. Dekker, Anthony F. Suffredini, Edward Septimus, Stephanie Bonne and Rui Wang and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Sameer S. Kadri

97 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014

2017 1.2k citations Chanu Rhee, Raymund Dantes et al. JAMA profile →
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents

2018 377 citations Sameer S. Kadri, Jennifer Adjemian et al. Clinical Infectious Diseases profile →
Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use

2020 232 citations Chanu Rhee, Sameer S. Kadri et al. JAMA Network Open profile →
Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series — 465 Health Care Facilities, United States, December 2020–October 2021

2022 135 citations Christina Yek, Sarah Warner et al. profile →

Peers

Countries citing papers authored by Sameer S. Kadri

Since Specialization

Citations

This map shows the geographic impact of Sameer S. Kadri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer S. Kadri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer S. Kadri more than expected).

Fields of papers citing papers by Sameer S. Kadri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sameer S. Kadri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer S. Kadri. The network helps show where Sameer S. Kadri may publish in the future.

Co-authorship network of co-authors of Sameer S. Kadri

This figure shows the co-authorship network connecting the top 25 collaborators of Sameer S. Kadri. A scholar is included among the top collaborators of Sameer S. Kadri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sameer S. Kadri. Sameer S. Kadri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New Kids on the Block: Estimating Use of Next-generation Gram-negative Antibiotics Across Greater Than 700 Hospitals in the United States 2025 ·Open Forum Infectious Diseases ·Anthony D. Harris, Katherine E Goodman, Lisa Pineles, Morgan Walker, Jacqueline Bork, Emily L. Heil, Kimberly C. Claeys, Justin Brooks, Sameer S. Kadri, Bradley A. Maron, Jonathan Baghdadi	1
2	Impact of the COVID-19 Pandemic on Antibiotic Resistant Infection Burden in U.S. Hospitals 2025 ·Annals of Internal Medicine ·Christina Yek, (unknown), Guoqing Diao, Morgan Walker, Maniraj Neupane, (unknown), (unknown), Mary Richert, Chanu Rhee, Michael Klompas, Bruce Swihart, Sarah Warner, Sameer S. Kadri, (unknown), (unknown), (unknown)	4
3	Utilization patterns of hematology consultation in the intensive care unit: an 11-year single-center experience 2025 ·Blood Advances ·(unknown), Michael B. Streiff, Rakhi P. Naik, Nitin Seam, Sameer S. Kadri, Alfred Ian Lee, Melissa P. Knauert, George Goshua	0
4	Demographics, epidemiology, mortality and difficult-to-treat resistance patterns of bacterial bloodstream infections in the global US Military Health System from 2010 to 2019: a retrospective cohort study 2025 ·BMJ Open ·(unknown), (unknown), John H. Powers, Sameer S. Kadri, Sarah Warner, Uzo Chukwuma, (unknown), Charlotte Lanteri, M Leigh Carson, (unknown), (unknown), (unknown), Jing Wang, Edward Parmelee, Katrin Mende	0
5	Using a difficult-to-treat resistance index to gauge imbalance between countries' antibiotic resistance prevalence and access to antibiotics: a scoping review and concept proposal 2025 ·Clinical Microbiology and Infection ·Morgan Walker, (unknown), Christina Yek, (unknown), (unknown), Jennifer Cohn, Alicia A. Livinski, Sameer S. Kadri	1
6	Association Between Hospital Type and Resilience During COVID-19 Caseload Stress 2024 ·Annals of Internal Medicine ·Maniraj Neupane, Sarah Warner, (unknown), Junfeng Sun, Christina Yek, (unknown), (unknown), Mary Richert, (unknown), Morgan Walker, Bruce Swihart, Steven H. Mitchell, John L. Hick, Bram Rochwerg, Eddy Fan, Cumhur Y. Demirkale, Sameer S. Kadri	3
7	Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in U.S. Hospitals 2024 ·Annals of Internal Medicine ·Jeffrey R. Strich, (unknown), Guoqing Diao, Alexander Lawandi, (unknown), Cumhur Y. Demirkale, Ahmed Babiker, (unknown), Bruce Swihart, Morgan Walker, Christina Yek, Maniraj Neupane, (unknown), Sarah Warner, Sameer S. Kadri, (unknown), (unknown), (unknown), (unknown)	9
8	Focusing on antimicrobial resistant infections –are we missing the forest for the trees and the patients for pathogens? 2023 ·SHILAP Revista de lepidopterología ·Alexander Lawandi, Sameer S. Kadri, John H. Powers	1
9	Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper 2023 ·Clinical Infectious Diseases ·Chanu Rhee, Jeffrey R. Strich, Kathleen Chiotos, David C. Classen, Sara E. Cosgrove, (unknown), Emily L. Heil, Sameer S. Kadri, André C. Kalil, David N. Gilbert, Henry Masur, Edward Septimus, Daniel A. Sweeney, (unknown), Dean L. Winslow, Donald M. Yealy, Michael Klompas	20
10	Assessment of Hospital-Onset SARS-CoV-2 Infection Rates and Testing Practices in the US, 2020-2022 2023 ·JAMA Network Open ·Kelly M Hatfield, James Baggs, (unknown), Sarah Warner, John A. Jernigan, Sameer S. Kadri, Michael Klompas, Sujan Reddy	10
11	Risk of Misleading Conclusions in Observational Studies of Time-to-Antibiotics and Mortality in Suspected Sepsis 2023 ·Clinical Infectious Diseases ·Theodore R. Pak, Jessica G. Young, (unknown), Anna A. Agan, Laura DelloStritto, Michael R. Filbin, Sayon Dutta, Sameer S. Kadri, Edward Septimus, Chanu Rhee, Michael Klompas	29
12	Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP) 2023 ·Trials ·Abhishek Deshpande, (unknown), (unknown), (unknown), Larisa G. Tereshchenko, Bo Hu, Sameer S. Kadri, Michael Klompas, Michael B. Rothberg	0
13	Association Between Implementation of the Severe Sepsis and Septic Shock Early Management Bundle Performance Measure and Outcomes in Patients With Suspected Sepsis in US Hospitals 2021 ·JAMA Network Open ·Chanu Rhee, (unknown), Rui Wang, Sameer S. Kadri, David Fram, Huai-Chun Chen, Michael Klompas	45
14	Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use breakdown → 2020 ·JAMA Network Open ·Chanu Rhee, Sameer S. Kadri, John P. Dekker, Robert L. Danner, Huai-Chun Chen, David Fram, Fang Zhang, Rui Wang, Michael Klompas	232
15	Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study 2020 ·The Lancet Infectious Diseases ·Ahmed Babiker, Xiaobai Li, Yi Ling Lai, Jeffrey R. Strich, Sarah Warner, (unknown), John P. Dekker, Robert L. Danner, Sameer S. Kadri	55
16	External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals 2019 ·Open Forum Infectious Diseases ·Sameer S. Kadri, Yi Ling Lai, Emily Ricotta, Jeffrey R. Strich, Ahmed Babiker, Chanu Rhee, Michael Klompas, John P. Dekker, John H. Powers, Robert L. Danner, Jennifer Adjemian	42
17	2398. Utilization Practices of Ceftazidime–Avibactam at Academic Medical Centers in the United States 2018 ·Open Forum Infectious Diseases ·Jeffrey R. Strich, Emily Ricotta, Yi Ling Lai, Samuel F. Hohmann, (unknown), Chanu Rhee, Michael Klompas, Tara N. Palmore, John H. Powers, John P. Dekker, Jennifer Adjemian, Robert L. Danner, Sameer S. Kadri	1
18	Granulocyte transfusions in the management of invasive fungal infections 2017 ·British Journal of Haematology ·Kamille A. West, Juan Gea‐Banacloche, David F. Stroncek, Sameer S. Kadri	33
19	Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014 breakdown → 2017 ·JAMA ·Chanu Rhee, Raymund Dantes, Lauren Epstein, David J. Murphy, Christopher Seymour, Theodore J. Iwashyna, Sameer S. Kadri, Derek C. Angus, Robert L. Danner, Anthony E. Fiore, John A. Jernigan, Greg S. Martin, Edward Septimus, David K. Warren, Anita Karcz, Christina K. Chan, John T. Menchaca, Rui Wang, Susan Gruber, Michael Klompas	1214
20	Estimating Ten-Year Trends in Septic Shock Incidence and Mortality in United States Academic Medical Centers Using Clinical Data 2016 ·CHEST Journal ·Sameer S. Kadri, Chanu Rhee, Jeffrey R. Strich, Megan K. Morales, Samuel F. Hohmann, (unknown), Anthony F. Suffredini, Robert L. Danner, Michael Klompas	161

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact